Latest filing published 17 Feb 2022 for Sensei Biotherapeutics, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Robert Hamilton Pierce: trading record in brief
Robert Hamilton Pierce is a declared insider of Faeth Therapeutics, Inc. (chief executive), with filings sourced from SEC (Form 4). Between 6 August 2021 and 15 February 2022, the trades on record add up to 5 filings.
Every open-market trade on record is a sale: 4 sales worth €585k. Other entries cover 1 share grant.
The record was last updated on 17 February 2022 with a share grant in Faeth Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert Hamilton Pierce
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 21,000 shares0Common StockSEC:0001209191-22-010982:0
- 16,030 shares@ US$7.343672.1% of flowCommon StockSEC:0001209191-21-051172:0
- 6,460 shares@ US$7.112727.9% of flowCommon StockSEC:0001209191-21-050659:0
3 of 3 declarations
